Abstract
In the extracellular environment, the enzyme transglutaminase 2 (TG2) is involved in cell–matrix interactions through association with the extracellular matrix protein, fibronectin (FN). The 45 kDa gelatin-binding domain of FN (45FN) is responsible for the binding to TG2. Previous studies have demonstrated that the FN-binding site of TG2 is located in the N-terminal domain of the enzyme although with conflicting results regarding the specific residues involved. Here we have mapped the FN interaction site of human TG2 by use of hydrogen/deuterium exchange coupled with mass spectrometry, and we confirm that the FN-binding site is located in the N-terminal domain of TG2. Furthermore, by combination of site-directed mutagenesis and surface plasmon resonance analysis we have identified the TG2 residues K30, R116 and H134 as crucial to maintain the high affinity interaction with FN. Mutation of all three residues simultaneously reduced binding to 45FN by more than 2000-fold. We also identified residues in the catalytic core domain of TG2 that contributed to FN binding, hence extending the binding interface between TG2 and FN. This study provides new insights into the high affinity interaction between TG2 and FN.





Similar content being viewed by others
Abbreviations
- TG2:
-
Transglutaminase 2
- FN:
-
Fibronectin
- 45FN:
-
45 kDa proteolytic fibronectin fragment (gelatin-binding domain)
- ECM:
-
Extracellular matrix
- HDX-MS:
-
Hydrogen/deuterium exchange coupled with mass spectrometry
- SPR:
-
Surface plasmon resonance
- WT:
-
Wild-type
- RH:
-
TG2 mutant R116A/H134A
- KRH:
-
TG2 mutant K30E/R116A/H134A
- mAb:
-
Monoclonal antibody
References
Achyuthan KE, Rowland TC, Birckbichler PJ et al (1996) Hierarchies in the binding of human factor XIII, factor XIIIa, and endothelial cell transglutaminase to human plasma fibrinogen, fibrin, and fibronectin. Mol Cell Biochem 162:43–49
Adamczyk M, Griffiths R, Dewitt S et al (2015) P2X7 receptor activation regulates rapid unconventional export of transglutaminase-2. J Cell Sci Sci 128:4615–4628
Akimov SS, Belkin AM (2001) Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98:1567–1576
Akimov SS, Krylov D, Fleischman LF, Belkin AM (2000) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 148:825–838
Bergamini CM, Signorini M, Poltronieri L (1987) Inhibition of erythrocyte transglutaminase by GTP. Biochim Biophys Acta 916:149–151
Cao L, Petrusca DN, Satpathy M et al (2008) Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling. Carcinogenesis 29:1893–1900
Cao L, Shao M, Schilder J et al (2012) Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene 31:2521–2534
Cardoso I, Stamnaes J, Andersen JT et al (2015) Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies. FEBS J 282:2063–2075
Chen X, Hnida K, Graewert MA et al (2015) Structural basis for antigen recognition by transglutaminase 2-specific autoantibodies in celiac disease. J Biol Chem 290:21365–21375
Clarke DD, Mycek MJ, Neidle A, Waelsch H (1959) The incorporation of amines into protein. Arch Biochem Biophys 79:338–354
Di Niro R, Sulic A-M, Mignone F et al (2010) Rapid interactome profiling by massive sequencing. Nucleic Acids Res 38:e110
Eckert RL, Fisher ML, Grun D et al (2015) Transglutaminase is a tumor cell and cancer stem cell survival factor. Mol Carcinog 54:947–958
Engvall E, Ruoslahti E, Miller EJ (1978) Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med 147:1584–1595
Erat MC, Slatter DA, Lowe ED et al (2009) Identification and structural analysis of type I collagen sites in complex with fibronectin fragments. Proc Natl Acad Sci USA 106:4195–4200
Foss S, Watkinson RE, Grevys A et al (2016) TRIM21 immune signaling is more sensitive to antibody affinity than its neutralization activity. J Immunol 196:3452–3459
Fuller GM, Doolittle RF (1966) The formation of crosslinked fibrins: evidence for the involvement of lysine epsilon-amino groups. Biochem Biophys Res Commun 25:694–700
Furie M, Rifkin D (1980) Proteolytically derived fragments of human plasma fibronectin and their localization within the intact molecule. J Biol Chem 255:3134–3140
Hang J, Zemskov EA, Lorand L, Belkin AM (2005) Identification of a novel recognition sequence for fibronectin within the NH2-terminal β-sandwich domain of tissue transglutaminase. J Biol Chem 280:23675–23683
He W, Sun Z, Liu Z (2015) Silencing of TGM2 reverses epithelial to mesenchymal transition and modulates the chemosensitivity of breast cancer to docetaxel. Exp Ther Med 10:1413–1418
Iversen R, Di Niro R, Stamnaes J et al (2013) Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells. J Immunol 190:5981–5991. doi:10.4049/jimmunol.1300183
Iversen R, Mysling S, Hnida K et al (2014) Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange. Proc Natl Acad Sci USA 111:17146–17151
Jang TH, Lee DS, Choi K et al (2014) Crystal structure of transglutaminase 2 with GTP complex and amino acid sequence evidence of evolution of GTP binding site. PLoS One 9:1–8
Jeong JM, Murthy S, Radek JT, Lorand L (1995) The fibronectin-binding domain of transglutaminase. J Biol Chem 270:5654–5658
LeMosy EK, Erickson HP, Beyer WF et al (1992) Visualization of purified fibronectin-transglutaminase complexes. J Biol Chem 267:7880–7885
Liu S, Cerione RA, Clardy J (2002) Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci USA 99:2743–2747
Lorand L, Graham RM (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4:140–156
Lortat-Jacob H, Burhan I, Scarpellini A et al (2012) Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix. J Biol Chem 287:18005–18017
Molberg O, Mcadam SN, Körner R et al (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4:713–717
Mosesson MW, Chen AB, Huseby RM (1975) The cold-insoluble globulin of human plasma: studies of its essential structural features. Biochim Biophys Acta 386:509–524
Mycek MJ, Clarke DD, Neidle A, Waelsch H (1959) Amine incorporation into insulin as catalyzed by transglutaminase. Arch Biochem Biophys 84:528–540
Pankov R (2002) Fibronectin at a glance. J Cell Sci 115:3861–3863
Piacentini M, D’Eletto M, Farrace MG et al (2014) Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological states. Cell Tissue Res 358:793–805
Pinkas DM, Strop P, Brunger AT, Khosla C (2007) Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol 5:e327
Radek JT, Jeong JM, Murth S et al (1993) Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin. Proc Natl Acad Sci USA 90:3152–3156
Ruoslahti E, Hayman EG, Engvall E et al (1981) Alignment of biologically active domains in the fibronectin molecule. J Biol Chem 256:7277–7281
Satpathy M, Cao L, Pincheira R et al (2007) Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase. Cancer Res 67:7194–7202
Scarpellini A, Germack R, Lortat-Jacob H et al (2009) Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2. J Biol Chem 284:18411–18423
Sollid LM, Molberg O, McAdam S, Lundin KEA (1997) Autoantibodies in coeliac disease: tissue transglutaminase–guilt by association? Gut 41:851–852
Stamnaes J, Fleckenstein B, Sollid LM (2008) The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions. Biochim Biophys Acta Proteins Proteomics 1784:1804–1811
Stamnaes J, Pinkas DM, Fleckenstein B et al (2010) Redox regulation of transglutaminase 2 activity. J Biol Chem 285:25402–25409
Stephens P, Grenard P, Aeschlimann P et al (2004) Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci 117:3389–3403
Turner P, Lorand L (1989) Complexation of fibronectin with tissue transglutaminase. Biochemistry 28:628–635
Verderio EAM, Telci D, Okoye A et al (2003) A novel RGD-independent cel adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis. J Biol Chem 278:42604–42614
Yakubov B, Chelladurai B, Schmitt J et al (2013) Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer. Neoplasia 15:609–619
Yakubov B, Chen L, Belkin AM et al (2014) Small molecule inhibitors target the tissue transglutaminase and fibronectin interaction. PLoS One 9:e89285
Zemskov EA, Janiak A, Hang J et al (2006) The role of tissue transglutaminase in cell-matrix interactions. Front Biosci 11:1057–1076
Zemskov EA, Mikhailenko I, Hsia R-C et al (2011) Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes. PLoS One 6:e19414
Acknowledgments
This work was supported by the European Commission grants MRTN-CT-2006-036032 and ERC-2010-Ad-268541 and Grants from the Research Council of Norway and the South-Eastern Norway Regional Health Authority. The authors thank Chaitan Khosla (Stanford University, CA; USA) for providing the TG3 plasmid.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human and animal rights statement
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Handling Editors: S. Beninati, M. Piacentini, C.M. Bergamini.
Electronic supplementary material
Below is the link to the electronic supplementary material.
726_2016_2296_MOESM1_ESM.tif
Supplementary material 1 Supplementary Fig. 1 Deuterium uptake plots for all identified TG2 peptides which showed no difference in D-uptake when comparing the 45FN-bound state (red curves) and the unbound state (blue curves). Error bars represent SD based on labeling triplicates (TIFF 2358 kb)
Rights and permissions
About this article
Cite this article
Cardoso, I., Østerlund, E.C., Stamnaes, J. et al. Dissecting the interaction between transglutaminase 2 and fibronectin. Amino Acids 49, 489–500 (2017). https://doi.org/10.1007/s00726-016-2296-y
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s00726-016-2296-y


